Endovenous Microwave Ablation Versus Laser Ablation for Small Saphenous Vein Varicosis Weiqin LuJinsong JiangGuangwei Yang Original Research 24 April 2024 Pages: 2342 - 2351
Stratified Patient Profiling for Vedolizumab Effectiveness in Crohn’s Disease: Identifying Optimal Subgroups for Enhanced Treatment Response in the EVOLVE Study Andres YarurGerassimos J. MantzarisBrian Bressler Original Research Open access 24 April 2024 Pages: 2324 - 2341
Correction to: Psychometric Evaluation of the MENQOL Instrument in Women Experiencing Vasomotor Symptoms Associated with Menopause Neil M. SchultzAntonia MorgaStephanie E. Rhoten Publisher Correction Open access 23 April 2024 Pages: 2543 - 2543
Correction to: Association Between Bowel Wall Thickening and Long-Term Outcomes in Decompensated Liver Cirrhosis Xueying WangMin DingXingshun Qi Correction 23 April 2024 Pages: 2542 - 2542
Cost-Effectiveness of Recombinant Factor IX Fc Prophylaxis and Recombinant Factor IX On-Demand Treatment in Patients with Haemophilia B Without Inhibitors Michal PochopienAnna TytułaDaniel Eriksson Original Research Open access 23 April 2024 Pages: 2307 - 2323
Efgartigimod and Ravulizumab for Treating Acetylcholine Receptor Auto-antibody-Positive (AChR-Ab+) Generalized Myasthenia Gravis: Indirect Treatment Comparison Cécile van SteenLorenzo CelicoSergio Iannazzo Brief Report Open access 20 April 2024 Pages: 2486 - 2499
Primary Management of Operable Locally Advanced Oral Cavity Squamous Cell Carcinoma: Current Concepts and Strategies Ameya A. AsarkarBrent A. ChangAlfio Ferlito Review 20 April 2024 Pages: 2133 - 2150
Real-World Data on Therapies for Relapsed or Refractory Multiple Myeloma: Key Data from ASH 2023—A Podcast Luciano J. CostaPaula Rodriguez-Otero Commentary Open access 20 April 2024
Reduction in Diabetes-Related Hospitalizations and Medical Costs After Dexcom G6 Continuous Glucose Monitor Initiation in People with Type 2 Diabetes Using Intensive Insulin Therapy Katia L. HannahPoorva M. NemlekarGregory J. Norman Original Research Open access 15 April 2024 Pages: 2299 - 2306
Real-World Treatment Patterns and Healthcare Resource Use for Ulcerative Colitis and Crohn’s Disease in Italy Melania DovizioSusanne HartzAlessandro Armuzzi Original Research Open access 15 April 2024 Pages: 2282 - 2298
Comparative Effectiveness of Valoctocogene Roxaparvovec and Prophylactic Factor VIII Replacement in Severe Hemophilia A Johannes OldenburgHerve ChambostMargareth Ozelo Original Research Open access 15 April 2024 Pages: 2267 - 2281
Treatment-Free Interval: A Novel Approach to Assessing Real-World Treatment Effectiveness and Economic Impact Among Patients with Irritable Bowel Syndrome with Diarrhea Brian E. LacyPatrick Gagnon-SanschagrinAnkur A. Dashputre Original Research Open access 15 April 2024 Pages: 2253 - 2266
Real-World Effectiveness and Safety of Ramucirumab as a Second-Line Treatment for Patients with Unresectable Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma in Japan and South Korea: A Systematic Literature Review Xiaotian ZhangLi ZhouLin Shen Review Open access 15 April 2024 Pages: 2112 - 2132
Rationale and Design of the IMPROVE Trial: A Multicenter, Randomized, Controlled, Open-label, Blinded-endpoint Trial Assessing the Efficacy of Remote Ischemic Conditioning in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting Yang YanChangying ZhaoGuoliang Li Study Protocol 15 April 2024
Correction to: Real-World Safety and Effectiveness of an 8-Week Regimen of Glecaprevir/Pibrentasvir in Patients with Hepatitis C and Cirrhosis Mei LuLoralee B. RuppStuart C. Gordon Correction Open access 10 April 2024 Pages: 2534 - 2535
Exploring the Content Validity of the Unified Wilson Disease Rating Scale: Insights from Qualitative Research Stella KarantzoulisKarli HeuerMegan Teynor Original Research Open access 04 April 2024 Pages: 2070 - 2082
Safety and Efficacy of Pegcetacoplan in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria over 48 Weeks: 307 Open-Label Extension Study Christopher J. PatriquinAndrija BogdanovicJens Panse Original Research Open access 04 April 2024 Pages: 2050 - 2069
Perceptions and Experiences of People with Obesity and Type 2 Diabetes Around Appetite and Eating Behaviors: A Qualitative Study Jiat Ling PoonLouise OHaraBrad Mason Original Research Open access 01 April 2024 Pages: 2028 - 2049
Modelling Treatment Sequences in Immunology: Optimizing Patient Outcomes Rose J. HartFareen HassanDawn Lee Original Research Open access 30 March 2024 Pages: 2010 - 2027
Pharmacological Basis of Differences in Dose Response, Dose Equivalence, and Duration of Action of Inhaled Corticosteroids Peter T. Daley-YatesBhumika AggarwalMaximilian Plank Original Research Open access 27 March 2024 Pages: 1995 - 2009
Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims Analysis Benjamin ChastekAdam CarreraDavid Staskin Brief Report Open access 23 March 2024 Pages: 2086 - 2097
Assessing the Effects of Metabolic Disruption, Body Mass Index and Inflammation on Depressive Symptoms in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine Angela T. H. KwanZiji GuoRoger S. McIntyre Original Research 23 March 2024 Pages: 1983 - 1994
Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study Eun-Gyoung HongKyung-Wan MinHak Chul Jang Original Research Open access 21 March 2024 Pages: 1967 - 1982
Clinical Management of Patients with Non-Small Cell Lung Cancer, Brain Metastases, and Actionable Genomic Alterations: A Systematic Literature Review Mustafa KhasrawPriyanka YalamanchiliEnriqueta Felip Review Open access 21 March 2024 Pages: 1815 - 1842
‘Totality of Evidence’ Approach in the Development of GP2017, an Approved Adalimumab Biosimilar Norman GaylisCharlotte BothPaul Yamauchi Review Open access 21 March 2024 Pages: 1795 - 1814
Enhancing Drug Management, Cost Savings, and Staff Satisfaction in Anesthesiology: A Quality Improvement Project in a Chinese Tertiary Hospital Xiaomin XingHaijun QuFanbo Jing Original Research 18 March 2024 Pages: 1953 - 1966
Matching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell Lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor Gilles SallesJenny M. H. ChenBijal Shah Original Research Open access 18 March 2024 Pages: 1938 - 1952
Adjusted Indirect Treatment Comparison of Progression-Free Survival with D-Rd and VRd Based on MAIA and SWOG S0777 Individual Patient-Level Data Brian G. M. DurieShaji K. KumarThierry Facon Original Research Open access 18 March 2024 Pages: 1923 - 1937
Correction to: PRESTO 2: An International Survey to Evaluate Patients’ Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly Dermot O’ToolePamela L. KunzAlly Prebtani Correction 13 March 2024 Pages: 2531 - 2533
Correction to: Comparative Efficacy, Durability and Safety of Faricimab in the Treatment of Diabetic Macular Edema: A Systematic Literature Review and Network Meta-Analysis Claire WatkinsTatiana PauloMarloes Bagijn Correction Open access 13 March 2024 Pages: 2084 - 2085
Correction to: The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis Awad AlshahraniNaji KholaifMoeber Mahzari Correction Open access 13 March 2024 Pages: 2083 - 2083
Perioperative and Long-Term Outcomes in Patients Undergoing Synchronous Carotid Endarterectomy and Coronary Artery Bypass Grafting: A Single-Center Experience Paimann NawroziThomas RatschillerAndreas Zierer Original Research Open access 13 March 2024 Pages: 1911 - 1922
Adverse Drug Events Observed with the Newly Approved Remimazolam in Comparison to Propofol for General Anesthesia in Patients Undergoing Surgery: A Meta-analysis Lidan HuangHong LiuSong Tao Original Research 13 March 2024 Pages: 1896 - 1910
Comparison of Healthcare Costs for Women with Treated Versus Untreated Vasomotor Symptoms Due to Menopause Aki ShiozawaShayna MancusoHelen M. Trenz Original Research Open access 11 March 2024 Pages: 1885 - 1895
The Humanistic and Economic Burden Associated with Major Depressive Disorder: A Retrospective Cross-Sectional Analysis Larry CulpepperAshley MartinMousam Parikh Original Research Open access 11 March 2024 Pages: 1860 - 1884
Relevance of Adalimumab Product Attributes to Patient Experience in the Biosimilar Era: A Narrative Review Jessica R. AllegrettiJessica H. BradyAlvin Wells Review Open access 11 March 2024 Pages: 1775 - 1794
Efficacy and Safety of Transitioning to Lemborexant from Z-drug, Suvorexant, and Ramelteon in Japanese Insomnia Patients: An Open-label, Multicenter Study Motohiro OzoneSusumu HirotaNaohisa Uchimura Original Research Open access 09 March 2024 Pages: 1728 - 1745
Incidence and Costs of Clinically Significant Events with Systemic Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study Daniel J. SimmonsStephen J. ValerioJanvi Sah Original Research Open access 05 March 2024 Pages: 1711 - 1727
Increased Nasal Blimp1 + Treg Cells After Sublingual Immunotherapy Reflect the Efficacy of Treatment in Allergic Rhinitis Yue PanXinxin ZhangLei Cheng Original Research 05 March 2024 Pages: 1698 - 1710
Left Atrial Strain Insights in Atrial Fibrillation and the Interplay with Metabolic Syndrome Hyun-Jin KimHyun-Sun Kim Original Research 05 March 2024 Pages: 1685 - 1697
Satisfaction with the Injection Experience of a New, Citrate-Free Formulation of Ixekizumab Sanjay ChabraJulie BirtW. Chad Cragun Original Research Open access 05 March 2024 Pages: 1672 - 1684
An Update on Stiripentol Mechanisms of Action: A Narrative Review Alexandre BacqAntoine DepaulisMarc Verleye Review Open access 05 March 2024 Pages: 1351 - 1371
Patient and Clinician Perspectives: To Create a Better Future for Chronic Kidney Disease, We Need to Talk About Our Kidneys Pamela R. KushnerJane DeMeisNavdeep Tangri Commentary Open access 05 March 2024 Pages: 1318 - 1324
Study Design of a Phase 2/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT Dédée F. MurrellPascal JolyArsalan Shabbir Study Protocol Open access 05 March 2024
Correction to: Association of Patient Satisfaction with Cataract Grading in Five Types of Multifocal IOLs Sana NiaziZisis GatzioufasFarideh Doroodgar Correction 02 March 2024 Pages: 1774 - 1774
Treatment Patterns with Mirabegron and Antimuscarinics for Overactive Bladder: A Prospective, Registry Study in Taiwan and South Korea (FAITH) Seung-June OhSung Tae ChoBudiwan Sumarsono Original Research Open access 02 March 2024 Pages: 1652 - 1671
Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies Nandita KheraMarie Louise EdwardsUsama Gergis Original Research Open access 01 March 2024 Pages: 1637 - 1651
Identification of a Group of Therapeutic Targets and Prognostic Biomarker for Triple Negative Breast Cancer Yan LiShengjie YangXinghe Wang Original Research 29 February 2024 Pages: 1621 - 1636
Selective Internal Radiation Therapy Using Y-90 Resin Microspheres for Metastatic Colorectal Cancer: An Updated Systematic Review and Network Meta-Analysis André L. F. Azeredo-da-SilvaVictor Hugo F. de JesusPatricia K. Ziegelmann Original Research Open access 26 February 2024 Pages: 1606 - 1620
Improved Quality of Life in Patients with Psoriasis Receiving Apremilast: Real-World Data from the Netherlands Juul M. P. A. van den ReekRobert J. T. van der LeestElke M. G. J. de Jong Original Research 24 February 2024 Pages: 1594 - 1605